Preguntas Frecuentes

Preguntas Frecuentes

Monoclonal antibodies are laboratory-made proteins that mimic the immune system’s ability to fight off harmful viruses like SARS-CoV-2. Monoclonal antibodies attack the virus and reduce its ability to spread throughout your body.

No. Vaccination remains the most powerful tool against contracting Covid-19, as well as against hospitalization and death from Covid. mAbs is a therapy that helps those who have tested positive for Covid-19.

Yes. Those who test positive for COVID-19  are eligible to receive monoclonal antibody treatment even if previously vaccinated.
Si, aunque se recomienda esperar 90 días después del tratamiento para recibir la vacuna.
No. Los anticuerpos no contienen al virus vivo.

Los Anticuerpos Monoclonales (mAbs) han sido autorizados por la FDA para uso de emergencia. Cualquier infusión o inyección puede causar efectos secundarios como: dolor breve, sangrado, moretones, dolor, hinchazón, fiebre, escalofríos, agotamiento, náuseas, dolor de cabeza y posible infección en el área de la infusión. Raramente pueden ocurrir reacciones alérgicas e hipersensibilidad durante o después de la infusión de anticuerpos. Por esta razón, usted será monitoreado por personal de salud entrenado durante y después del tratamiento.

Early treatment with mAbs may prevent the disease from worsening and lessen the length of your symptoms. Additionally, it can protect your household from contracting Covid from you.

Yes, monoclonal antibody treatment is administered at no cost to the patient. It is covered by all insurances.

Fill out your zip code on our website to get started. Once you qualify, we’ll reach out to you to schedule treatment. Treatment will be administered by a trained professional in the comfort of your own home. You can also search for a site by going to the U.S. Department of Health and Human Services website, or by calling them at 1-877-332-6585 (for English) or 1-877-366-0310 (for Spanish).

Español de México